BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35780841)

  • 1. Ellagic acid ameliorates high fructose-induced hyperuricemia and non-alcoholic fatty liver in Wistar rats: Focusing on the role of C1q/tumor necrosis factor-related protein-3 and ATP citrate lyase.
    Elseweidy MM; Elesawy AE; Sobh MS; Elnagar GM
    Life Sci; 2022 Sep; 305():120751. PubMed ID: 35780841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTRP3 ameliorates fructose-induced metabolic associated fatty liver disease via inhibition of xanthine oxidase-associated oxidative stress.
    Zhang J; Xu J; Lin X; Tang F; Tan L
    Tissue Cell; 2021 Oct; 72():101595. PubMed ID: 34303283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allopurinol Prevents the Lipogenic Response Induced by an Acute Oral Fructose Challenge in Short-Term Fructose Fed Rats.
    García-Arroyo FE; Monroy-Sánchez F; Muñoz-Jiménez I; Gonzaga G; Andrés-Hernando A; Zazueta C; Juárez-Rojas JG; Lanaspa MA; Johnson RJ; Sánchez-Lozada LG
    Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31614639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allopurinol ameliorates high fructose diet induced hepatic steatosis in diabetic rats through modulation of lipid metabolism, inflammation, and ER stress pathway.
    Cho IJ; Oh DH; Yoo J; Hwang YC; Ahn KJ; Chung HY; Jeong SW; Moon JY; Lee SH; Lim SJ; Jeong IK
    Sci Rep; 2021 May; 11(1):9894. PubMed ID: 33972568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raspberry ketone ameliorates nonalcoholic fatty liver disease in rats by activating the AMPK pathway.
    Askar ME; Ali SI; Younis NN; Shaheen MA; Zaher ME
    Eur J Pharmacol; 2023 Oct; 957():176001. PubMed ID: 37598925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lycopene ameliorates hyperlipidemia via potentiation of AMP-activated protein kinase and inhibition of ATP-citrate lyase in diabetic hyperlipidemic rat model.
    Elseweidy MM; Elawady AS; Sobh MS; Elnagar GM
    Life Sci; 2022 Nov; 308():120934. PubMed ID: 36075470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression.
    Abd El-Haleim EA; Bahgat AK; Saleh S
    World J Gastroenterol; 2016 Mar; 22(10):2931-48. PubMed ID: 26973390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
    Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
    Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endurance exercise-mediated metabolic reshuffle attenuates high-caloric diet-induced non-alcoholic fatty liver disease.
    Cook JJ; Wei M; Segovia B; Cosio-Lima L; Simpson J; Taylor S; Koh Y; Kim S; Lee Y
    Ann Hepatol; 2022; 27(4):100709. PubMed ID: 35489641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin treatment reverses high fat diet- induced non-alcoholic fatty liver diseases and dyslipidemia by stimulating multiple antioxidant and anti-inflammatory pathways.
    Yasmin T; Rahman MM; Khan F; Kabir F; Nahar K; Lasker S; Islam MD; Hossain MM; Hasan R; Rana S; Alam MA
    Biochem Biophys Rep; 2021 Dec; 28():101168. PubMed ID: 34825068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Betaine prevented fructose-induced NAFLD by regulating LXRα/PPARα pathway and alleviating ER stress in rats.
    Ge CX; Yu R; Xu MX; Li PQ; Fan CY; Li JM; Kong LD
    Eur J Pharmacol; 2016 Jan; 770():154-64. PubMed ID: 26593707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds.
    Xu C; Wan X; Xu L; Weng H; Yan M; Miao M; Sun Y; Xu G; Dooley S; Li Y; Yu C
    J Hepatol; 2015 Jun; 62(6):1412-9. PubMed ID: 25623823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of AMPK Entails the Protective Effect of Royal Jelly against High-Fat-Diet-Induced Hyperglycemia, Hyperlipidemia, and Non-Alcoholic Fatty Liver Disease in Rats.
    Felemban AH; Alshammari GM; Yagoub AEA; Al-Harbi LN; Alhussain MH; Yahya MA
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allopurinol decreases serum uric acid level and intestinal glucose transporter-5 expression in rats with fructose-induced hyperuricemia.
    Chen G; Jia P
    Pharmacol Rep; 2016 Aug; 68(4):782-6. PubMed ID: 27258609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatments with metformin and phosphodiesterase inhibitors alleviate nonalcoholic fatty liver disease in high-fat diet fed rats: a comparative study.
    Heeba GH; El-Deen RM; Abdel-Latif RG; Khalifa MMA
    Can J Physiol Pharmacol; 2020 Aug; 98(8):498-505. PubMed ID: 32083947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-targeting strategy to ameliorate high-fat-diet- and fructose-induced (western diet-induced) non-alcoholic fatty liver disease (NAFLD) with supplementation of a mixture of legume ethanol extracts.
    Koh YC; Lin YC; Lee PS; Lu TJ; Lin KY; Pan MH
    Food Funct; 2020 Sep; 11(9):7545-7560. PubMed ID: 32815965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of nonalcoholic fatty liver disease by swertiamarin in fructose-fed mice.
    Yang Y; Li J; Wei C; He Y; Cao Y; Zhang Y; Sun W; Qiao B; He J
    Phytomedicine; 2019 Jun; 59():152782. PubMed ID: 31005808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism.
    Zhou Y; Ding YL; Zhang JL; Zhang P; Wang JQ; Li ZH
    Biomed Pharmacother; 2018 Jan; 97():1397-1408. PubMed ID: 29156529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xanthine oxidase inhibition attenuates insulin resistance and diet-induced steatohepatitis in mice.
    Nishikawa T; Nagata N; Shimakami T; Shirakura T; Matsui C; Ni Y; Zhuge F; Xu L; Chen G; Nagashimada M; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S; Ota T
    Sci Rep; 2020 Jan; 10(1):815. PubMed ID: 31965018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ellagic acid attenuates high-carbohydrate, high-fat diet-induced metabolic syndrome in rats.
    Panchal SK; Ward L; Brown L
    Eur J Nutr; 2013 Mar; 52(2):559-68. PubMed ID: 22538930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.